Optinose to Present at the 2020 Jefferies Virtual Healthcare Conference

YARDLEY, Penn., May 26, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the 2020 Jefferies Virtual Healthcare Conference on June 2, 2020, at 1:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor ContactJonathan Neely[email protected]267.521.0531

You May Also Be Interested In

• Finland's Aalto Works joins the UNESCO World Heritage List, with five sites in Helsinki
• KuCoin Marks Ninth Anniversary at Tomorrowland Belgium, Honoring Nine Years of Industry Progress Beyond the Signal
• Fitzroy Minerals Intersects Wide Zones of Mineralization in Leachable Material Close to Surface at the Buen Retiro Copper Project, Chile